Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | TLR8 | Q9NR97 | 2/20 | 0.41 |
| ▸ | TYR | P14679 | 1/20 | 0.39 |
| ▸ | THRA | P10827 | 1/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.39 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.39 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.39 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.38 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.38 |
| ▸ | CTRC | Q99895 | 1/20 | 0.36 |
| ▸ | BID | P55957 | 2/20 | 0.36 |
| ▸ | BCL2L1 | Q07817 | 2/20 | 0.36 |
| ▸ | MCL1 | Q07820 | 2/20 | 0.36 |
| ▸ | BAK1 | Q16611 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL677130 | 0.93 | LIPG (0.55) | LIPGTLR8THRATHRBNR1H2 | |
| SCHEMBL677574 | 0.91 | LIPG (0.58) | LIPGCYP3A4TYRTHRATHRB | |
| SCHEMBL2919197 | 0.91 | LIPG (0.58) | LIPGCYP3A4TYRTHRATHRB | |
| SCHEMBL667814 | 0.91 | LIPG (0.58) | LIPGCYP3A4TYRTHRATHRB | |
| SCHEMBL9386103 | 0.91 | LIPG (0.58) | LIPGCYP3A4TYRTHRATHRB | |
| SCHEMBL29520482 | 0.88 | LIPG (0.56) | LIPGCYP3A4CYP2D6CYP2C9TLR8 | |
| SCHEMBL245188 | 0.88 | LIPG (0.56) | LIPGCYP3A4CYP2D6CYP2C9TLR8 | |
| SCHEMBL10497552 | 0.86 | LIPG (0.47) | LIPGCYP3A4CYP2D6CYP2C9TLR8 | |
| SCHEMBL18242680 | 0.86 | LIPG (0.47) | LIPGCYP3A4CYP2D6CYP2C9TLR8 | |
| SCHEMBL321423 | 0.86 | ADRA2B (0.39) | LIPG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 100 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101367819-B | 5-substituent-2-(4-substituted phenyl)-6,7-dihydrogen pyrazole-[1,5-a]pyrazine-4(5H)-ketone derivant and uses thereof | UNIV SHANDONG | 2010-08-18 | — | — | CN | claimed |
| CN-101633675-A | Preparation and application of 5-substituent group-6-substituent phenyl-2-ferrocenyl pyrazolo [1, 5-a] pyrazine-4(5H)-ketone derivative | UNIV SHANDONG | 2010-01-27 | — | — | CN | claimed |
| CN-101367819-A | 5-substituent-2-(4-substituted phenyl)-6,7-dihydrogen pyrazole-[1,5-a]pyrazine-4(5H)-ketone derivant and uses thereof | UNIV SHANDONG (CN) | 2009-02-18 | — | — | CN | claimed |
| US-4608391-A | NERUOUS SYSTEM DISORDERS, PARKINSON$S DISEASE | CORNELL RESEARCH FOUNDATION INC. (US) | 1986-08-26 | — | — | US | claimed |
| US-3975532-A | ANALGESIC | ICI UNITED STATES INC. (US) | 1976-08-17 | — | — | US | claimed |
| US-11718758-B2 | Aqueous dispersion of colored particles | MITSUBISHI PENCIL COMPANY, LIMITED (JP) | 2023-08-08 | — | — | US | disclosed |
| EP-3725854-B1 | COLORED PARTICLE AQUEOUS DISPERSION | MITSUBISHI PENCIL CO (JP) | 2023-07-05 | — | — | EP | disclosed |
| EP-3516019-B1 | LUBRICANT COMPOSITIONS STABILIZED BY MIXTURES OF DIARYLAMINE AND HYDROXYDIARYLAMINE ANTIOXIDANTS | LANXESS CORP (US) | 2023-06-14 | — | — | EP | disclosed |
| CN-111465662-B | Aqueous dispersion of coloured particles | 三菱铅笔株式会社 | 2023-05-26 | — | — | CN | disclosed |
| EP-3516020-B1 | ALKYLATED 3-HYDROXYDIPHENYLAMINE ANTIOXIDANTS | LANXESS CORP (US) | 2022-05-25 | — | — | EP | disclosed |
| US-20210071006-A1 | AQUEOUS DISPERSION OF COLORED PARTICLES | MITSUBISHI PENCIL COMPANY, LIMITED (JP) | 2021-03-11 | — | — | US | disclosed |
| US-20200407658-A1 | ALKYLATED ALKOXYDIARYLAMINE ANTIOXIDANTS | LANXESS SOLUTIONS US INC. (US) | 2020-12-31 | — | — | US | disclosed |
| EP-0783032-A1 | LUBRICATING OIL COMPOSITION | IDEMITSU KOSAN COMPANY LIMITED (JP) | 1997-07-09 | — | — | EP | disclosed |
| EP-0437016-B1 | Lipid A analogues having immunoactivating and anti-tumour activity | SANKYO CO (JP) | 1996-05-01 | — | — | EP | disclosed |
| EP-0593438-A1 | FUNGICIDAL COMPOSITIONS, FUNGICIDAL COMPOUNDS, THEIR PRODUCTION AND USE | DOWELANCO (US) | 1994-04-27 | — | — | EP | disclosed |
| EP-0437016-A2 | Lipid A analogues having immunoactivating and anti-tumour activity | Sankyo Company Limited (JP) | 1991-07-17 | — | — | EP | disclosed |
| US-4943519-A | Light sensitive, stabilized photographic recording material | AGFA-GEVAERT AKTIENGESELLSCHAFT (DE) | 1990-07-24 | — | — | US | disclosed |
| EP-0347840-A2 | Phosphinic acid derivates | BANYU PHARMACEUTICAL CO., LTD. (JP) | 1989-12-27 | — | — | EP | disclosed |
| EP-0229655-A2 | Morpholine derivatives containing substituted piperidine groups and use thereof as stabilizers | AUSIMONT S.r.l. (IT) | 1987-07-22 | — | — | EP | disclosed |
| US-3996193-A | POLYALKYLENEPOLYAMINES, DIOLEFIN RUBBER | THE DOW CHEMICAL COMPANY (US) | 1976-12-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200407658-A1 | ALKYLATED ALKOXYDIARYLAMINE ANTIOXIDANTS | GPX4, CAT, SOD1 | LIPG 146/4885CYP3A4 403/4885CYP2D6 366/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.